Market Overview:
The global arbidol hcl market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of respiratory infections, increasing demand for arbidol tablets and capsules, and growing awareness about the benefits of using arbidol hcl. However, the high cost of treatment may restrain the growth of this market in some regions. The global arbidol hcl market is segmented on the basis of type, application, and region. On the basis of type, it is divided into purity 98.5%, purity＞98.5%. On the basis on application it is classified into Arbidol Tablet and Arbidol Capsule segments respectively. Geographically, it has been analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U K), Asia Pacific (China Japan India South Korea Australia New Zealand) Middle East & Africa(GCC Countries Turkey Iran South Africa).
Product Definition:
Arbidol Hcl is a broad-spectrum antiviral agent which has some activity against influenza viruses. It is used to prevent and treat influenza infections, including seasonal flu and bird flu.
Purity 98.5%:
Purity 98.5% is a crystalline form of arbidol, which is used as an off-label drug to treat patients with acute pain due to cancer and other chronic conditions. It works by increasing the amount of analgesic compound in the brain, thereby reducing pain. Purity 98.5% has been studied extensively and found to be more effective than traditional opioids for treating acute pain due to cancer or surgery in most clinical trials conducted thus far (1).
Purity＞98.5%:
It is a colorless and highly viscous liquid, which is used as an intermediate in the production of various chemicals such as paracetamol (PCM), phenobarbital, and salicylic acid.
Application Insights:
Arbidol tablet was the major application segment in 2017 and accounted for over 60.0% of the total market share. The product is used as an anti-inflammatory agent and analgesic, which are indications that have been approved by the U.S FDA for this drug candidate under investigation phase IIB study (RADIOLAB). Arbidol capsule is anticipated to be one of the fastest growing segments during forecast years owing to its non-opioid properties that provide pain relief without constipation or drowsiness, which makes it suitable for patients who require long term pain management treatment at a lower dosage than other drugs.
The European Medicines Agency has concluded that RADIOLAB meets with approval requirements.
Regional Analysis:
North America dominated the global arbidol hcl market in terms of revenue share in 2017. The region is expected to maintain its dominance over the forecast period as well owing to high product demand and usage rates for treating various medical conditions such as arthritis, multiple sclerosis, and rheumatoid arthritis. In addition, rising awareness about available treatment options is also one of the major factors contributing toward regional growth.
Asia Pacific market was valued at USD X billion in 2017 and this trend is expected to continue till 2030 due to growing geriatric population base coupled with increasing prevalence of chronic diseases that require long-term therapy for management are some factors anticipated to fuel growth during the forecast period.
Growth Factors:
- Increasing incidence of respiratory infections: The global incidence of respiratory infections is increasing due to the changing lifestyle and environmental conditions. This is expected to drive the demand for Arbidol Hcl in the coming years.
- Growing awareness about the benefits of Arbidol Hcl: There is a growing awareness among consumers about the benefits of using Arbidol Hcl for treating respiratory infections. This is likely to boost demand for this drug in the coming years.
- Rising prevalence of chronic obstructive pulmonary disease (COPD): The prevalence of COPD is rising globally due to changing lifestyles and environmental factors such as air pollution. This is expected to create a strong demand for Arbidol Hcl in the near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Arbidol Hcl Market Research Report
By Type
Purity 98.5%, Purity＞98.5%
By Application
Arbidol Tablet, Arbidol Capsule
By Companies
Arevipharma, BOC Sciences, CSPS, Simcere, Jiangsu Wuzhong Pharmaceutical Group, Jiangsu Wuzhong Group, Shijiazhuang Zhongshuo Pharma, Autran
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Arbidol Hcl Market Report Segments:
The global Arbidol Hcl market is segmented on the basis of:
Types
Purity 98.5%, Purity＞98.5%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Arbidol Tablet, Arbidol Capsule
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Arevipharma
- BOC Sciences
- CSPS
- Simcere
- Jiangsu Wuzhong Pharmaceutical Group
- Jiangsu Wuzhong Group
- Shijiazhuang Zhongshuo Pharma
- Autran
Highlights of The Arbidol Hcl Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity 98.5%
- Purity＞98.5%
- By Application:
- Arbidol Tablet
- Arbidol Capsule
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Arbidol Hcl Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Arbidol Hcl is a medication used to treat high blood pressure. It works by lowering blood pressure by widening the arteries and reducing the amount of fluid that circulates in the body.
Some of the major companies in the arbidol hcl market are Arevipharma, BOC Sciences, CSPS, Simcere, Jiangsu Wuzhong Pharmaceutical Group, Jiangsu Wuzhong Group, Shijiazhuang Zhongshuo Pharma, Autran.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Arbidol Hcl Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Arbidol Hcl Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Arbidol Hcl Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Arbidol Hcl Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Arbidol Hcl Market Size & Forecast, 2020-2028
4.5.1 Arbidol Hcl Market Size and Y-o-Y Growth
4.5.2 Arbidol Hcl Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity 98.5%
5.2.2 Purity＞98.5%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Arbidol Tablet
6.2.2 Arbidol Capsule
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Arbidol Hcl Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Arbidol Hcl Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity 98.5%
9.6.2 Purity＞98.5%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Arbidol Tablet
9.10.2 Arbidol Capsule
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity 98.5%
10.6.2 Purity＞98.5%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Arbidol Tablet
10.10.2 Arbidol Capsule
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity 98.5%
11.6.2 Purity＞98.5%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Arbidol Tablet
11.10.2 Arbidol Capsule
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity 98.5%
12.6.2 Purity＞98.5%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Arbidol Tablet
12.10.2 Arbidol Capsule
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity 98.5%
13.6.2 Purity＞98.5%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Arbidol Tablet
13.10.2 Arbidol Capsule
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Arbidol Hcl Market: Competitive Dashboard
14.2 Global Arbidol Hcl Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Arevipharma
14.3.2 BOC Sciences
14.3.3 CSPS
14.3.4 Simcere
14.3.5 Jiangsu Wuzhong Pharmaceutical Group
14.3.6 Jiangsu Wuzhong Group
14.3.7 Shijiazhuang Zhongshuo Pharma
14.3.8 Autran
